Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Bibliographic Details
Main Authors: Andrew Kent, Eduardo Davila, Jitao Guo
Format: Article
Language:English
Published: BMJ Publishing Group 2021-08-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/8/1.1.full
id doaj-37bba60754944344b28ec4d028ad3b41
record_format Article
spelling doaj-37bba60754944344b28ec4d028ad3b412021-08-10T10:00:17ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-08-019810.1136/jitc-2019-000218corr1Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cellsAndrew Kent0Eduardo Davila1Jitao Guo2Division of Medical Oncology, Department of Medicine, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USADivision of Medical Oncology, Department of Medicine, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USADivision of Medical Oncology, Department of Medicine, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USAhttps://jitc.bmj.com/content/9/8/1.1.full
collection DOAJ
language English
format Article
sources DOAJ
author Andrew Kent
Eduardo Davila
Jitao Guo
spellingShingle Andrew Kent
Eduardo Davila
Jitao Guo
Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Journal for ImmunoTherapy of Cancer
author_facet Andrew Kent
Eduardo Davila
Jitao Guo
author_sort Andrew Kent
title Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
title_short Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
title_full Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
title_fullStr Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
title_full_unstemmed Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
title_sort correction: cd3xcd19 dart molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2021-08-01
url https://jitc.bmj.com/content/9/8/1.1.full
work_keys_str_mv AT andrewkent correctioncd3xcd19dartmoleculetreatmentinducesnonapoptotickillingandisefficientagainsthighriskchemotherapyandvenetoclaxresistantchroniclymphocyticleukemiacells
AT eduardodavila correctioncd3xcd19dartmoleculetreatmentinducesnonapoptotickillingandisefficientagainsthighriskchemotherapyandvenetoclaxresistantchroniclymphocyticleukemiacells
AT jitaoguo correctioncd3xcd19dartmoleculetreatmentinducesnonapoptotickillingandisefficientagainsthighriskchemotherapyandvenetoclaxresistantchroniclymphocyticleukemiacells
_version_ 1721212349272031232

Similar Items